Overview

Seaside founders understand the toll that brain development disorders, including intellectual disabilities and autism, take on families and share the sense of frustration that effective therapeutics are still not available despite recent scientific advances.

Seaside Therapeutics was founded to fill this void and to develop potential treatments for these underserved populations by translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families. Our lead drug development programs are currently focused on creating new treatments to correct or improve the course of Fragile X Syndrome and autism. We also continue to evaluate discoveries and explore opportunities to develop novel therapeutics for patients with other disorders of brain development.